Your Monday morning biotech news roundup
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we discuss why Sanofi's stock crashed,…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hey there. Today, we discuss why Sanofi’s stock crashed, what Sarepta’s new Duchenne data will mean for the company and the space, and say goodbye to Bristol Myers Squibb’s chief executive.
What's Your Reaction?
